Related Articles
Fibroblast growth factor‑21 is a potential diagnostic factor for patients with gestational diabetes mellitus
Adverse effects of gestational diabetes-related risk factors on pregnancy outcomes and intervention measures
Potential impact of <em>GCK</em>, <em>MIR-196A-2</em> and <em>MIR-423</em> gene abnormalities on the development and progression of type 2 diabetes mellitus in Asir and Tabuk regions of Saudi Arabia
Expression of miR‑409‑5p in gestational diabetes mellitus and its relationship with insulin resistance
Evaluation of oral glucose tolerance test, β‑cell function and adverse obstetric outcomes